Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialPeter Sever, Jan Östergren, Björn Dahlöf et al.|The Lancet|2003Cited by 3.8k
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trialBjörn Dahlöf, Jan Östergren, Peter Sever et al.|The Lancet|2005Cited by 2.9k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continentsEmanuele Di Angelantonio, Frank B. Hu, Zhengming Chen et al.|The Lancet|2016Cited by 2.8k
Interpretation of the evidence for the efficacy and safety of statin therapyRory Collins, Richard Peto, Christina Reith et al.|The Lancet|2016Cited by 1.8k
Association of Apolipoprotein E Genotypes With Lipid Levels and Coronary RiskAnna M. Bennet, John Danesh, Emanuele Di Angelantonio et al.|JAMA|2007Cited by 794